Company News: Pfizer (PFE) quarterly earnings beat analysts’ estimate

Market news

31 October 2017

Company News: Pfizer (PFE) quarterly earnings beat analysts’ estimate

Pfizer (PFE) reported Q3 FY 2017 earnings of $0.67 per share (versus $0.61 in Q3 FY 2016), beating analysts' consensus estimate of $0.65.

The company's quarterly revenues amounted to $13.168 bln (+0.9% y/y), generally in-line with analysts' consensus estimate of $13.175 bln.

The company also raised guidance for FY2017 EPS to $2.58-2.62 from $2.54-2.60 versus analysts' consensus estimate of $2.56, as well as for FY2017 revenues to $52.4-53.1 bln from $52.0-54.0 bln versus analysts' consensus estimate of $52.76 bln.

PFE rose to $35.38 (+0.65%) in pre-market trading.

Canada: Industrial Product Price Index, m/m, September -0.3% (forecast 0.4%)

Seasonally adjusted GDP rose by 0.6% in both the euro area (EA19) and in the EU28 during the third quarter

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.